Previous Page  13 / 14 Next Page
Information
Show Menu
Previous Page 13 / 14 Next Page
Page Background

allied

academies

Page 27

International Journal of Respiratory Medicine

|

Volume 3

LUNG CANCER AND COPD

5

th

International Congress on

J u n e 2 5 - 2 6 , 2 0 1 8 | A m s t e r d a m , N e t h e r l a n d s

Rabindra Nath Das, Int J Respir Med 2018, Volume 3

FORCED EXPIRATORY VOLUME

FACTORS OF STAGE III NON-SMALL

CELL LUNG CANCER PATIENTS

Rabindra Nath Das

University of Burdwan, India

Objectives:

Forced expiratory volume in 1 (FEV1) second is known as the

amount of air volume that can forcibly be blown out in one second, after full

inspiration. Average FEV1 values between 80% and 120% are considered as

normal. The determinants of FEV1 are aimed to identify in the report for stage

III non-small cell lung cancer (SIIINSCLC) patients.

Background:

Previous research articles have reported that the average FEV1

values in healthy individuals depend on height, age, body mass index, sex and

ethnicity. Little studies have been performed regarding the FEV1 determinants

for SIIINSCLC patients.

Materials & Methods:

Published records on 239 SIIINSCLC patients with 23

study characters (variables/factors) are considered in the present study.

The study variable FEV1 is positive and heterogeneous. Statistical analysis

technique namely, joint generalized linear Log-normal models is used for

analyzing the response FEV1.

Results:

The mean FEV1 (MFEV1) is higher for SIIINSCLC patients who

are current smoker (P=0.0601), or who have lower body mass index (BMI)

(P=0.0599). Location of tumor is positively partially related (P=0.2365) with

the MFEV1. The MFEV1 is higher for SIIINSCLC patients with histology level at

squamous cell carcinoma (P=0.1088), or T-stage at level (T2=2) (P=0.1752),

or N-stage at level (N2=3) (P=0.1440) and (N4 or Nx=4) (P=0.0142) than the

other levels. The MFEV1 is higher for SIIINSCLC patients with chemotherapy

at levels (standard sequential=3) (P<0.0001) and (standard concurrent=4)

(P<0.0001), than the patientswith no chemo level. The FEV1 variance (FEV1V)

is higher for SIIINSCLC patients at older ages (P=0.1282), or never/ex-smoker

patients (P=0.2985). The FEV1V increases as the number of positive lymph

node stations increases (P=0.0017). The FEV1V is inversely related with

T-stage at level (T2=2) (P=0.0172) and at level (T4 or Tx=4) (P=0.0240). The

FEV1V decreases at the higher equivalent dose (P=0.1822), or at larger gross

tumor volume (P=0.0003), or at higher survival times (P=0.0451).

Conclusion:

The FEV1 determinants for both the mean and variance have

been identified for SIIINSCLC patients. These resultsmay help the lung cancer

specialists. The current findings of FEV1 (related to SIIINSCLC patients) are

new addition to the lung cancer literature.

Rabindra Nath Das is a Professor in the Depart-

ment of Statistics, The University of Burdwan,

Burdwan, West Bengal, India. He holds PhD in

statistics, from The University of Burdwan, In-

dia, and Post-Doc from Seoul National Univer-

sity, Seoul, Korea. He has authored about 85

research articles, and along with a research

monograph entitled- Robust Response Sur-

faces, Regression, and Positive Data Analyses,

published from CRC Press, Taylor and Francis,

Chapman and Hall. He wrote research articles

on design of experiments, Regression Analysis,

Demography, Quality Engineering, Civil Engi-

neering, Epidemiology, Medical sciences, En-

vironmental, Natural sciences etc. His special

area of interest is on Design of experiments,

Regression analysis, Quality Engineering and

Epidemiology. He has received ‘Gopal Kanji

Prize 2009’ by the Journal of Applied Statistics

and Routledge publications’ for the best article

published in the journal, entitled– A measure

of robust slope-rotatability for second-order

response surface experimental designs. He

has received certificate of appreciation for out-

standing research by the Editor-In-Chief, Journal

of Thyroid Science.

rabin.bwn@gmail.com

BIOGRAPHY